November 2016 Interim Update to the Guidelines

Update to the Pharmacologic Management of Type 2 Diabetes

Following the results of recent cardiovascular outcome studies of antihyperglycemic therapies, the recommendations for Pharmacologic Management of Type 2 Diabetes from the 2013 guidelines have been updated. Please refer to the following links to access the published update from the Canadian Journal of Diabetes along with other updated resources on the Guidelines website and App.

Healthcare Provider Tools

• Pharmacotherapy for Type 2 Interactive Tool
• Clinical Practice Guidelines Quick Reference Guide in both English and French
• Quick Reference Guide – Blood Glucose-Lowering Therapies (Type 2 Diabetes)

Related Chapters

• Chapter 13 Pharmacologic Management of Type 2 Diabetes : November 2016 Interim Update
• Chapter 13 Figure 1 – Management of hyperglycemia in type 2 diabetes
• Chapter 13 Table 1 – Antihyperglycemic agents for use in type 2 diabetes

Slides and Videos

• English Slide Decks – Essentials 190, Essentials 63, Essentials 30, Essentials Victor, Chapter 13

February 2016 Interim Update to the Guidelines

Update to the Pharmacologic Management of Type 2 Diabetes

Following the results of recent cardiovascular outcome studies of antihyperglycemic therapies, the recommendations for Pharmacologic Management of Type 2 Diabetes from the 2013 guidelines have been updated. Please refer to the following links to access the published update from the Canadian Journal of Diabetes along with other updated resources on the Guidelines website and App.

Healthcare Provider Tools

• Pharmacotherapy for Type 2 Interactive Tool
• Quick Reference Guide – Blood Glucose-Lowering Therapies (Type 2 Diabetes)
• Appendix 5 – Approximate Cost Reference List for Antihyperglycemic Agents
• Clinical Practice Guidelines Quick Reference Guide in both English and French

Related Chapters

• Chapter 13 Pharmacologic Management of Type 2 Diabetes : February 2016 Interim Update
• Chapter 13 Figure 1 – Management of hyperglycemia in type 2 diabetes
• Chapter 13 Table 1 – Antihyperglycemic agents for use in type 2 diabetes
• Chapter 13 Figure 2 – Antihyperglycemic medications and renal function

Slides and Videos

• English Slide Decks – Essentials 190, Essentials 63, Essentials 30, Essentials Victor, Chapter 12, Chapter 13, Chapter 17, Chapter 37
• English Videos – Essentials, Chapter 12, Chapter 13, Chapter 17, Chapter 37

2015 Interim Update to the Guidelines

New Addition to the Pharmacologic Management of Type 2 Diabetes

The sodium glucose link transporter 2 (SGLT2) inhibitors have been added to the Pharmacologic Management of Type 2 Diabetes chapter of the 2013 guidelines. Please refer to the following links to access the published update from the Canadian Journal of Diabetes along with other resources on the guidelines website that has been updated.

Healthcare Provider Tools

• Pharmacotherapy for Type 2 Interactive Tool
• Clinical Practice Guidelines Quick Reference Guide in both English and French

Related Chapters

• Chapter 13 Pharmacologic Management of Type 2 Diabetes - 2015 Interim Update
• Chapter 13 Figure 1 – Management of hyperglycemia in type 2 diabetes
• Chapter 13 Figure 2 – Antihyperglycemic medications and renal function
• Chapter 13 Table 1 – Antihyperglycemic agents for use in type 2 diabetes
• Appendix 6 – Therapeutic Considerations for Renal Impairment
• Appendix 7 – Sick Day Medication List

Case Studies

• The Case Studies under the Blood Glucose Lowering Section

Slides and Videos

• English Slide Decks – Essentials 190, Essentials 63, Essentials 30, Essentials Victor, Chapter 12, Chapter 13, Chapter 17, Chapter 29, Chapter 37
• English Videos – Chapter 12, Chapter 13, Chapter 17, Chapter 29, Chapter 37